Kazia Therapeutics (KZIA) Short Interest Ratio & Short Volume $3.02 -0.01 (-0.33%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Kazia Therapeutics Short Interest DataKazia Therapeutics (KZIA) has a short interest of 22,300 shares. This marks a -36.29% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 398,975 shares to cover all short positions.Current Short Interest22,300 sharesPrevious Short Interest35,000 sharesChange Vs. Previous Month-36.29%Dollar Volume Sold Short$115,291.00Short Interest Ratio0.2 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares4,355,000 sharesPercentage of Shares Shorted0.51%Today's Trading Volume59,686 sharesAverage Trading Volume398,975 sharesToday's Volume Vs. Average15% Short Selling Kazia Therapeutics? Sign up to receive the latest short interest report for Kazia Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKZIA Short Interest Over TimeKZIA Days to Cover Over TimeKZIA Percentage of Float Shorted Over Time Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Kazia Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202422,300 shares $115,291.00 -36.3%N/A0.2 $5.17 11/15/202435,000 shares $159,950.00 +86.2%N/A0.2 $4.57 10/31/202418,800 shares $101,520.00 -88.5%N/A0.1 $5.40 10/15/2024164,000 shares $54,136.40 -47.4%N/A0.1 $0.33 9/30/2024311,600 shares $133,956.84 -80.5%N/A0 $0.43 9/15/20241,600,000 shares $548,960.00 +388.1%N/A0.1 $0.34 Get the Latest News and Ratings for KZIA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kazia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024327,800 shares $138,757.74 -21.8%N/A0 $0.42 8/15/2024418,900 shares $161,276.50 +85.0%N/A0 $0.39 7/31/2024226,400 shares $84,447.20 -93.3%N/A0 $0.37 7/15/20243,380,000 shares $1.89 million +7,076.2%N/A0.3 $0.56 6/30/202447,100 shares $10,767.06 +97.9%N/A0 $0.23 6/15/202423,800 shares $5,475.55 -10.2%N/A0.1 $0.23 5/31/202426,500 shares $6,890.00 -45.0%N/A0.1 $0.26 5/15/202448,200 shares $13,009.18 -44.0%N/A0.1 $0.27 4/30/202486,000 shares $28,792.80 +367.4%N/A0.1 $0.33 4/15/202418,400 shares $5,648.80 -92.9%N/A0 $0.31 3/31/2024259,500 shares $80,393.10 +6.9%N/A0.3 $0.31 3/15/2024242,800 shares $54,362.92 -68.3%N/A0.3 $0.22 2/29/2024765,100 shares $195,177.01 +1,566.9%N/A1.1 $0.26 2/15/202445,900 shares $14,242.77 -74.7%N/A0.1 $0.31 1/31/2024181,700 shares $54,328.30 +54.5%N/A1 $0.30 1/15/2024117,600 shares $41,148.24 +103.1%N/A1.1 $0.35 12/31/202357,900 shares $25,447.05 +32.8%N/A0.6 $0.44 12/15/202343,600 shares $17,047.60 -40.3%N/A0.5 $0.39 11/30/202373,000 shares $40,931.10 -35.6%N/A0.9 $0.56 11/15/2023113,400 shares $87,658.20 +1,889.5%N/A1.6 $0.77 10/31/20235,700 shares $2,393.43 -95.0%N/A0.1 $0.42 10/15/2023113,800 shares $77,384.00 +116.8%N/A3.1 $0.68 9/30/202352,500 shares $52,250.63 +10.3%N/A1.3 $1.00 9/15/202347,600 shares $48,076.00 -24.3%N/A0.3 $1.01 8/31/202362,900 shares $57,245.29 +10.5%N/A0.3 $0.91 8/15/202356,900 shares $51,329.49 -33.5%N/A0.3 $0.90 7/31/202385,600 shares $86,456.00 -2.5%N/A0.5 $1.01 7/15/202387,800 shares $76,745.98 -36.8%N/A0.5 $0.87 6/30/2023139,000 shares $158,460.00 -3.6%N/A0.8 $1.14 6/15/2023144,200 shares $181,692.00 -10.7%N/A4.7 $1.26 5/31/2023161,500 shares $192,185.00 +20.3%N/A4.8 $1.19 5/15/2023134,300 shares $178,619.00 -24.4%N/A3 $1.33 4/30/2023177,700 shares $236,341.00 +28.2%N/A3.9 $1.33 4/15/2023138,600 shares $182,952.00 -2.0%N/A2.8 $1.32This Indicator called BOTH NVDA rallies (Ad)Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. 3/31/2023141,400 shares $145,656.14 +10.0%N/A2.7 $1.03 3/15/2023128,600 shares $120,768.26 -8.5%N/A2.2 $0.94 2/28/2023140,600 shares $129,352.00 -3.8%N/A2.3 $0.92 2/15/2023146,100 shares $131,490.00 -17.3%N/A2.6 $0.90 1/31/2023176,700 shares $182,001.00 -28.5%N/A2.8 $1.03 1/15/2023247,100 shares $259,455.00 +64.2%N/A0.7 $1.05 12/30/2022150,500 shares $92,542.45 -7.8%N/A0.4 $0.61 12/15/2022163,300 shares $89,145.47 -6.1%N/A0.5 $0.55 11/30/2022173,900 shares $104,966.04 -3.4%N/A0.5 $0.60 11/15/2022180,100 shares $118,866.00 -75.8%N/A0.5 $0.66 10/31/2022744,000 shares $614,767.20 +526.3%N/A2.1 $0.83 10/15/2022118,800 shares $118,800.00 +7.1%N/A0.4 $1.00 9/30/2022110,900 shares $121,990.00 -5.9%N/A0.4 $1.10 9/15/2022117,900 shares $168,597.00 -20.7%N/A0.3 $1.43 8/31/2022148,700 shares $227,511.00 -24.8%N/A0.2 $1.53 8/15/2022197,700 shares $345,975.00 +68.7%N/A0.3 $1.75 7/31/2022117,200 shares $425,436.00 -19.0%N/A0.2 $3.63 7/15/2022144,600 shares $539,358.00 +113.9%N/A0.4 $3.73 6/30/202267,600 shares $283,920.00 +90.4%N/A0.2 $4.20 6/15/202235,500 shares $191,700.00 +86.8%N/A0.1 $5.40 5/31/202219,000 shares $110,010.00 -21.2%N/A0.7 $5.79 5/15/202224,100 shares $132,309.00 +225.7%N/A1.2 $5.49 4/30/20227,400 shares $47,582.00 -53.5%N/A0.5 $6.43 4/15/202215,900 shares $121,317.00 +45.9%N/A1.2 $7.63 3/31/202210,900 shares $84,039.00 +445.0%N/A0.7 $7.71 3/15/20222,000 shares $12,100.00 -79.4%N/A0.1 $6.05 2/28/20229,700 shares $65,184.00 +592.9%N/A0.5 $6.72 2/15/20221,400 shares $10,514.00 +55.6%N/A0.1 $7.51 1/31/2022900 shares $6,030.00 -64.0%N/A0 $6.70 1/15/20222,500 shares $19,500.00 -19.4%N/A0.1 $7.80 12/31/20213,100 shares $26,102.00 -59.2%N/A0.1 $8.42 12/15/20217,600 shares $55,860.00 +20.6%N/A0.3 $7.35 11/30/20216,300 shares $63,189.00 +162.5%N/A0.2 $10.03 11/15/20212,400 shares $26,856.00 +4.4%N/A0.1 $11.19 10/29/20212,300 shares $24,909.00 -37.8%N/A0.1 $10.83 10/15/20213,700 shares $38,850.00 -67.8%N/A0.1 $10.50 9/30/202111,500 shares $130,180.00 -27.7%N/A0.5 $11.32 9/15/202115,900 shares $165,042.00 -29.0%N/A0.6 $10.38 8/31/202122,400 shares $243,040.00 +21.7%N/A0.7 $10.85 8/13/202118,400 shares $174,800.00 -18.6%N/A0.6 $9.50 7/30/202122,600 shares $204,078.00 -3.0%N/A0.6 $9.03 7/15/202123,300 shares $223,214.00 -16.5%N/A0.6 $9.58 6/30/202127,900 shares $275,094.00 +57.6%N/A0.5 $9.86 6/15/202117,700 shares $189,921.00 -18.1%N/A0.2 $10.73 5/28/202121,600 shares $205,416.00 -14.3%N/A0.2 $9.51 5/14/202125,200 shares $239,904.00 -38.2%N/A0.2 $9.52 4/30/202140,800 shares $444,720.00 +1,175.0%N/A0.3 $10.90 4/15/20213,200 shares $36,544.00 -88.5%N/A0 $11.42 3/31/202127,700 shares $333,508.00 -27.1%N/A0.2 $12.04 3/15/202138,000 shares $417,240.00 +32.9%N/A0.3 $10.98This Indicator called BOTH NVDA rallies (Ad)Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. 2/26/202128,600 shares $297,154.00 +236.5%N/A0.2 $10.39 2/12/20218,500 shares $85,850.00 -18.3%N/A0 $10.10 1/29/202110,400 shares $99,424.00 -35.0%N/A0 $9.56 1/15/202116,000 shares $164,640.00 No ChangeN/A0 $10.29 1/15/20205,400 shares $24,624.00 -73.3%N/A0.1 $4.56 12/31/201920,200 shares $89,700.12 -70.5%N/A0.3 $4.44 KZIA Short Interest - Frequently Asked Questions What is Kazia Therapeutics' current short interest? Short interest is the volume of Kazia Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 22,300 shares of KZIA short. Learn More on Kazia Therapeutics' current short interest. Is Kazia Therapeutics' short interest increasing or decreasing? Kazia Therapeutics saw a decline in short interest in November. As of November 30th, there was short interest totaling 22,300 shares, a decline of 36.3% from the previous total of 35,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kazia Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kazia Therapeutics: Atlantic Coastal Acquisition Corp. II (0.49%), Aileron Therapeutics, Inc. (0.92%), BioVie Inc. (10.36%), Cardio Diagnostics Holdings, Inc. (4.52%), Virios Therapeutics, Inc. (2.44%), Dyadic International, Inc. (0.90%), Estrella Immunopharma, Inc. (0.37%), ImmuCell Co. (0.29%), Gain Therapeutics, Inc. (2.31%), Passage Bio, Inc. (3.38%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Kazia Therapeutics stock? Short selling KZIA is an investing strategy that aims to generate trading profit from Kazia Therapeutics as its price is falling. KZIA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kazia Therapeutics? A short squeeze for Kazia Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KZIA, which in turn drives the price of the stock up even further. How often is Kazia Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KZIA, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies ACAB Short Squeeze ALRN Short Squeeze BIVI Short Squeeze CDIO Short Squeeze VIRI Short Squeeze DYAI Short Squeeze ESLA Short Squeeze ICCC Short Squeeze GANX Short Squeeze PASG Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KZIA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kazia Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Kazia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
